3 Year Absolute Returns
36.71% ↑
NAV (₹) on 20 Aug 2026
26.51
1 Day NAV Change
0.14%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment of ₹100. The ... Read more
AUM
₹ 3,639.29 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 66.38% |
| Hospitals & Medical Services | 16.70% |
| Foreign Securities | 8.35% |
| Treps/Reverse Repo | 5.93% |
| Finance - Non Life Insurance | 1.08% |
| International Mutual Fund Units | 0.87% |
| Net Receivables/(Payables) | 0.53% |
| Medical Equipment & Accessories | 0.16% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 8.42% | ₹ 305.66 | Pharmaceuticals |
| IPCA Laboratories Ltd | 8.17% | ₹ 296.49 | Pharmaceuticals |
| Cipla Ltd | 8.13% | ₹ 294.84 | Pharmaceuticals |
| Sai Life Sciences Ltd | 7.10% | ₹ 257.41 | Pharmaceuticals |
| Gland Pharma Ltd | 6.35% | ₹ 230.44 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 5.93% | ₹ 215.28 | Others |
| Apollo Hospitals Enterprise Ltd | 5.81% | ₹ 210.88 | Hospitals & Medical Services |
| Globus Medical Inc | 5.57% | ₹ 201.98 | Others |
| Alkem Laboratories Ltd | 4.66% | ₹ 169.01 | Pharmaceuticals |
| Cohance Lifesciences Ltd | 3.75% | ₹ 136.14 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd | 3.47% | ₹ 125.77 | Hospitals & Medical Services |
| Alembic Pharmaceuticals Ltd | 3.17% | ₹ 114.98 | Pharmaceuticals |
| Manipal Health Enterprises Ltd | 3.02% | ₹ 109.71 | Hospitals & Medical Services |
| Procter & Gamble Health Ltd | 2.90% | ₹ 105.20 | Pharmaceuticals |
| Kovai Medical Center And Hospital Ltd | 2.74% | ₹ 99.29 | Hospitals & Medical Services |
| Pfizer Ltd | 2.73% | ₹ 99.22 | Pharmaceuticals |
| Divi's Laboratories Ltd | 2.34% | ₹ 84.79 | Pharmaceuticals |
| Indoco Remedies Ltd | 1.96% | ₹ 71.24 | Pharmaceuticals |
| Concord Biotech Ltd | 1.95% | ₹ 70.57 | Pharmaceuticals |
| Intuitive Surgical Inc | 1.74% | ₹ 63.24 | Others |
| Unichem Laboratories Ltd | 1.59% | ₹ 57.73 | Pharmaceuticals |
| Syngene International Ltd | 1.33% | ₹ 48.22 | Pharmaceuticals |
| Nephrocare Health Services Ltd | 1.19% | ₹ 43.28 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Co Ltd | 1.08% | ₹ 39.20 | Finance - Non Life Insurance |
| Aarti Drugs Ltd | 0.99% | ₹ 36.02 | Pharmaceuticals |
| Abbott Laboratories | 0.88% | ₹ 31.85 | Others |
| Global X Funds - Global X Genomics & Biotechnology ETF | 0.87% | ₹ 31.64 | Others |
| Eris Lifesciences Ltd | 0.84% | ₹ 30.60 | Pharmaceuticals |
| Net Receivables/Payables | 0.53% | ₹ 29.79 | Others |
| Jupiter Life Line Hospitals Ltd | 0.47% | ₹ 17.12 | Hospitals & Medical Services |
| Laxmi Dental Ltd | 0.16% | ₹ 5.96 | Medical Equipment & Accessories |
| Grail Inc | 0.16% | ₹ 5.71 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.09% | 5.71% | 0.53% | 10.99% |
| Category returns | 4.95% | 7.39% | 6.92% | 23.87% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
What is the current NAV of DSP Healthcare Fund Regular IDCW?
What is the fund size (AUM) of DSP Healthcare Fund Regular IDCW?
What are the historical returns of DSP Healthcare Fund Regular IDCW?
What is the risk level of DSP Healthcare Fund Regular IDCW?
What is the minimum investment amount for DSP Healthcare Fund Regular IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article